Pages that link to "Q39295266"

The following pages link to Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a (Q39295266):

Displaying 12 items.

• Hepatitis C virus and type 2 diabetes (Q24658049) (← links)
• Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial (Q33961434) (← links)
• Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients (Q34367370) (← links)
• Potential treatment options and future research to increase hepatitis C virus treatment response rate (Q34576190) (← links)
• Hepatitis C Virus Infection: Molecular Pathways to Steatosis, Insulin Resistance and Oxidative Stress (Q35259669) (← links)
• Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient. (Q37701225) (← links)
• Current understanding of insulin resistance in hepatitis C. (Q37903853) (← links)
• Steatosis and insulin resistance in response to treatment of chronic hepatitis C (Q37974700) (← links)
• How to use virological tools for the optimal management of chronic hepatitis C (Q39793127) (← links)
• Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients (Q42995429) (← links)
• The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients (Q42999928) (← links)
• IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. (Q43035545) (← links)